Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
![]() |
fig.3.c
Shifley ET et al. (2012) |
Xla Wt + dnfgfr1
NF35/36 (in situ hybridization) |
|
|||||
![]() |
fig.S6
Kenny AP et al. (2012) |
Xla Wt + fn1 MO
NF35/36 (in situ hybridization) |
|
|||||
![]() |
fig.6.r
Kenny AP et al. (2012) |
Xla Wt + szl MO
NF35/36 (in situ hybridization) |
|
|||||
![]() |
fig.3.c
Kenny AP et al. (2012) |
Xla Wt + szl MO
NF37/38 (in situ hybridization) |
|
|||||
![]() |
fig 6.d,e
Li Y et al. (2008) |
Xla Wt + Mmu.lef1-Mmu.ctnnb1-GR + DEX
NF35/36 (in situ hybridization) |
|
|||||
![]() |
fig 2.O
Li Y et al. (2008) |
Xla Wt + sfrp5
NF35/36 (in situ hybridization) |
|
|||||
![]() |
fig 2.N
Li Y et al. (2008) |
Xla Wt + sfrp5 MO
NF35/36 (in situ hybridization) |
|
|||||
![]() |
fig 2.V
Li Y et al. (2008) |
Xla Wt + sfrp5 MO
NF35/36 (in situ hybridization) |
|
|||||
![]() |
fig 6.d,e
Li Y et al. (2008) |
Xla Wt + sfrp5 MO
NF35/36 (in situ hybridization) |
|
|||||
![]() |
fig 7.a
Li Y et al. (2008) |
Xla Wt + sfrp5 MO
NF35/36 (in situ hybridization) |
|